LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $730,402

Key CONT_AWD_75N91025F00021_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 47 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91025F00021_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91025F00021_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:56:38Z

Content hash d43b497dc437b77428aff4de1fa5de234f21faeb588dd52a564b97b4a9e203ac

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$730,402	first version	September 12, 2025	July 20, 2026	2026-09-05T00:56:38Z	historical sweep	`d43b497dc437`

Archived copy

https://web.archive.org/web/20261017223103/https://www.usaspending.gov/award/CONT_AWD_75N91025F00021_7529_75N91019D00024_7529 captured by this system, October 17, 2026

What the amount is made of

2 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-08, when USAspending reported a total obligation of $730,402.

Action date	Modification	Type	Obligated	Description as recorded
July 20, 2026	P00001	OTHER ADMINISTRATIVE ACTION	+$668,886	MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE
September 12, 2025	base	not on file	+$61,516	MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE

Last refreshed November 4, 2026 at 2:31 PM UTC.